Drug reviewers question Pfizer pain drug data
497581
U.S. drug reviewers have questioned Pfizer Inc.'s  data showing the pain reliever Celebrex was as effective as an older drug in treating juvenile rheumatoid arthritis, according to documents released on Tuesday.
122874
Pfizer (PFE) said Friday that it has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial, but it has no plans to withdraw the drug.
303984
At least five medications now sold to consumers pose such risks that their sale should be limited or stopped, said a government drug reviewer who raised safety questions earlier about the arthritis drug Vioxx.
576668
Ina series of testy e-mail exchanges with his bosses, a federal drug-safety reviewer contends that an effort to publish his study demonstrating the dangers of Vioxx was delayed and demeaned
698387
FRIDAY, Dec. 17 (HealthDayNews) -- Pfizer Inc. said Friday that a study of its popular pain drug Celebrex in cancer patients had found an apparent increased risk of heart attack and other cardiovascular problems.
148326
NEW YORK - At the end of Pfizer&#39;s annual analyst meeting, Chief Executive Hank McKinnell dropped a bombshell. Older, over-the-counter pain medicines may not be safe for the heart, McKinnell said, because there
415629
20/12/2004 - The safety of cox-2 inhibitors was plunged into further uncertainty after Pfizer released details of trials that found an increased risk of heart problems with patients taking its painkiller Celebrex.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
130323
BEIJING, Dec. 24 -- FDA has recommended on Thursday that doctors and users are cautious to use the controversial painkillers -- Pfizer Inc.
421539
This morning, Pfizer (nyse: PFE - news - people ) announced that it had received data from two long-term studies in using its arthritis drug Celebrex to prevent cancer.
32784
The panel is examining claims that GlaxoSmithKline tried to suppress a doctorâs criticism of its drug Avandia.
742524
Pfizer Inc. and Canadian health officials moved Thursday to answer concerns over the painkiller Celebrex after a news report raised safety questions about the drug.
214469
Medicines watchdogs are reviewing safety data for an entire class of drugs taken by millions of patients with arthritis and severe pain after the worldwide withdrawal of Merck&#39;s Vioxx last week.
556546
Pfizer Inc. PFE.N, the world's  largest drug maker, said on Tuesday it was conducting a  comprehensive review of its operations, but said analyst  speculation it had decided to cut jobs was "premature."
343910
A veteran scientist at the Food and Drug Administration said yesterday he will present new, unpublished findings about heart risk associated with a number of pain drugs at a meeting to assess whether they are safe enough for patients.
764151
NEW YORK (Dow Jones/AP) -- Pfizer Inc. defended the safety of its painkiller Celebrex on Thursday after a newspaper reported that documents from Canadian health authorities linked the drug to the deaths of